Skip to main content
BrainCited

Ginkgo biloba Figures

32 figures from peer-reviewed research

All Alpha-Lipoic Acid Bacopa monnieri Citicoline Creatine Curcumin Folate Ginkgo biloba Green Tea Extract (EGCG) L-Theanine Lutein & Zeaxanthin Melatonin Omega-3 Fatty Acids (DHA/EPA) Panax Ginseng Phosphatidylserine Resveratrol Rhodiola rosea Taurine Uridine Monophosphate Vitamin B12 Vitamin D Vitamin E Zinc
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1 Diagram

Major pharmacotherapeutic targets in Alzheimer's disease are mapped, including amyloid-beta aggregation, tau hyperphosphorylation, neuroinflammation, and cholinergic dysfunction as key intervention points.

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional …

Figure 2
Figure 2 Diagram

The amyloid cascade hypothesis and its therapeutic targets are illustrated, showing how beta-secretase and gamma-secretase inhibitors, along with anti-amyloid antibodies, aim to reduce pathological plaque formation.

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional …

Figure 3
Figure 3 Diagram

Tau protein pathology and potential therapeutic interventions are depicted, including kinase inhibitors and immunotherapy approaches targeting neurofibrillary tangle formation in Alzheimer's disease.

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional …

Figure 4
Figure 4 Diagram

Neuroinflammatory pathways in Alzheimer's disease and anti-inflammatory therapeutic targets are outlined, showing microglial activation, cytokine cascades, and potential points of pharmacological intervention.

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional …

Figure 5
Figure 5 Diagram

Traditional medicinal plants investigated for Alzheimer's management are catalogued with their bioactive compounds and proposed neuroprotective mechanisms, including antioxidant and anti-inflammatory activities.

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional …

Figure 6
Figure 6 Diagram

Cholinergic system dysfunction in Alzheimer's disease and current cholinesterase inhibitor therapies are illustrated, showing how acetylcholine deficiency contributes to cognitive decline.

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional …

Figure 3
Figure 3

[Not Available].

Figure 4
Figure 4

[Not Available].

Figure 4 Diagram of the mechanism of GB on independent risk factors for atherosclerosis. Trimethylamine N-oxide (TMAO) levels in the blood can be utilized as a predictor of early atherosclerosis. Trimellitic anhydride (TMA) is derived from digested and ab
Figure 5

Figure 4 Diagram of the mechanism of GB on independent risk factors for atherosclerosis. Trimethylamine N-oxide (TMAO) levels in the blood can be utilized as a predictor of early atherosclerosis. …

[Not Available].

Figure 1
Figure 1

Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined …

Figure 6
Figure 6 Chart

Alpha diversity analysis of gut microbiota in Alzheimer's model mice treated with Ginkgo biloba extract. Shannon and Simpson diversity indices indicate shifts in microbial community richness and evenness following treatment.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 7
Figure 7 Chart

Beta diversity analysis using principal coordinate plots to compare gut microbial community structures across treatment groups. Distinct clustering patterns suggest Ginkgo biloba extract alters the overall composition of the gut microbiome in Alzheimer's model mice.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 8
Figure 8 Chart

Taxonomic composition of gut microbiota at the phylum level across experimental groups. Relative abundance of Firmicutes, Bacteroidetes, and other phyla is compared between Ginkgo biloba-treated and control Alzheimer's model mice.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 9
Figure 9 Chart

Genus-level taxonomic analysis of gut flora showing differential abundance of specific bacterial genera in response to Ginkgo biloba extract treatment. Several genera associated with short-chain fatty acid production appear enriched in the treatment group.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 10
Figure 10 Chart

LEfSe analysis identifying microbial biomarkers that distinguish Ginkgo biloba-treated mice from controls. Discriminant taxa are ranked by effect size, revealing key bacterial groups responsive to treatment.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 11
Figure 11 Diagram

Cladogram visualization of microbial taxa significantly associated with Ginkgo biloba extract treatment. Hierarchical taxonomic relationships from phylum to genus level highlight lineages that are differentially abundant between groups.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 12
Figure 12 Chart

Functional prediction analysis of gut microbial metabolic pathways using PICRUSt or similar tools. Metabolic categories enriched in Ginkgo biloba-treated Alzheimer's model mice suggest alterations in amino acid metabolism, lipid metabolism, and neurotransmitter-related pathways.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

*: p < 0.05.
Figure 13 Chart

Statistical comparison of specific microbial metabolites or pathway abundances between treatment groups, with significance indicated (*p < 0.05). Differential metabolic activity in the gut microbiome may be associated with the neuroprotective effects observed in the Ginkgo biloba group.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 14
Figure 14 Chart

Correlation analysis between gut microbiota composition and behavioral or neurological markers in Alzheimer's model mice. Spearman or Pearson correlation heatmaps reveal associations between specific bacterial genera and cognitive performance metrics.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 15
Figure 15 Diagram

Network analysis depicting co-occurrence patterns among gut microbial taxa in response to Ginkgo biloba treatment. Nodes represent bacterial genera and edges represent significant positive or negative correlations.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 16
Figure 16 Chart

Metabolomic profiling of cecal or fecal contents comparing Ginkgo biloba-treated and control groups. OPLS-DA or PCA score plots demonstrate separation of metabolic profiles between treatment conditions.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 17
Figure 17 Chart

Volcano plot or heatmap of differentially abundant metabolites identified in the gut of Ginkgo biloba-treated Alzheimer's model mice. Metabolites related to tryptophan, bile acid, and short-chain fatty acid pathways are highlighted.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 18
Figure 18 Diagram

Pathway enrichment analysis of significantly altered gut metabolites following Ginkgo biloba treatment. KEGG or MetaboAnalyst pathway maps indicate enrichment in neuroactive compound biosynthesis and anti-inflammatory metabolic routes.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Figure 19
Figure 19 Chart

Correlation matrix between differentially abundant gut metabolites and specific bacterial genera altered by Ginkgo biloba treatment. Strong associations suggest mechanistic links between microbial metabolism and the brain-gut axis in Alzheimer's disease.

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a …

Page 1 of 2